Risk Score Predicts High-Grade Prostate Cancer in DNA-Methylation Positive, Histopathologically Negative Biopsies

Neste Leander Van, Alan W Partin, Grant Stewart, Jonathan I Epstein, David J Harrison & Criekinge Wim Van
Background: Prostate cancer (PCa) diagnosis is challenging because efforts for effective, timely treatment of men with significant cancer typically result in over-diagnosis and repeat biopsies. The presence or absence of epigenetic aberrations, more specifically DNA-methylation of GSTP1, RASSF1 and APC, in histopathologically negative prostate core biopsies has resulted in an increased negative predictive value (NPV) of ~90% and thus could lead to a reduction of unnecessary repeat biopsies. Here, it is investigated whether, in methylation-positive...
This data repository is not currently reporting citations. For information on how your repository can report citations, please see our documentation.
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.